Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-05-31 4:23 pm Sale |
2024-05-13 | 13G | Turnstone Biologics Corp. TSBX |
Langer Timothy | 993,607 4.300% |
-299,613 (-23.17%) |
Filing History |
| 2024-04-29 08:22 am Sale |
2024-04-26 | 13G | Turnstone Biologics Corp. TSBX |
FMR CORP | 1,386,323 5.994% |
-1,160,338 (-45.56%) |
Filing History |
| 2024-03-18 9:13 pm Purchase |
2023-09-11 | 13G | Turnstone Biologics Corp. TSBX |
Langer Timothy | 1,293,220 5.600% |
1,293,220 (New Position) |
Filing History |
| 2024-02-09 10:05 am Sale |
2024-02-08 | 13G | Turnstone Biologics Corp. TSBX |
FMR CORP | 2,546,661 11.027% |
-372,126 (-12.75%) |
Filing History |
| 2023-08-03 4:41 pm Purchase |
2023-07-25 | 13D | Turnstone Biologics Corp. TSBX |
Versant Venture Capital V L.P. | 2,899,216 12.500% |
2,899,216 (New Position) |
Filing History |
| 2023-07-27 4:20 pm Purchase |
2023-07-25 | 13G | Turnstone Biologics Corp. TSBX |
Point72 Asset Management, L.P. | 1,383,314 6.200% |
1,383,314 (New Position) |
Filing History |
| 2023-07-27 08:57 am Purchase |
2023-07-27 | 13G | Turnstone Biologics Corp. TSBX |
FMR CORP | 2,918,787 13.154% |
2,918,787 (New Position) |
Filing History |
| 2023-07-24 4:33 pm Purchase |
2023-07-20 | 13D | Turnstone Biologics Corp. TSBX |
ORBIMED ADVISORS LLC | 3,099,265 13.400% |
3,099,265 (New Position) |
Filing History |